BNY Mellon named as Chr Hansen ADR programme depositary.
BANKING AND CREDIT NEWS-February 5, 2014--BNY Mellon named as Chr Hansen ADR programme depositary
(C)2014 M2 COMMUNICATIONS http://www.m2.com
5 February 2014 -- New York-based financial services firm BNY Mellon (NYSE: BK) said it has been appointed by Chr Hansen (OMX: CHR) (OTC: CHYHY) as depositary bank for its sponsored American depositary receipt programme.
Previously, the company traded in the US over-the-counter market as an unsponsored DR. Each Chr Hansen ADR represents one-half of an ordinary share and trades OTC under the symbol "CHYHY." Chr.
Founded in 1874, Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. Products include cultures, enzymes, probiotics and natural colors.
All solutions are based on strong research and development competencies, coupled with significant technology investments. The company has more than 2,500 employees in 30 countries and main production facilities in Denmark, France, the US and Germany.
BNY Mellon acts as depositary for more than 2,700 American and global depositary receipt programs, acting in partnership with leading companies from 68 countries.
Find out more at www.bnymellon.com/dr.
1 USD = 0.6131 GBP
((Comments on this story may be sent to firstname.lastname@example.org))